2019 tables: Institutions - Nature & Science - corporate

The 2019 tables are based on Nature Index data from 1 January 2018 to 31 December 2018.

Table criteria

# Institution Share 2017 Share 2018 Count 2018 Change in Adjusted Share 2017-2018*
1 Alphabet Inc., United States of America (USA) 2.20 4.88 9 106.4%
2 Merck & Co., Inc., United States of America (USA) 3.67 4.43 8 12.6%
3 IBM Corporation, United States of America (USA) 3.02 4.16 10 28.5%
4 Pfizer Inc., United States of America (USA) 0.11 1.48 5 1,169.9%
5 Amgen Inc., United States of America (USA) 0.90 1.38 7 42.3%
6 Bristol-Myers Squibb (BMS), United States of America (USA) 1.22 0.93 5 -28.3%
7 Johnson & Johnson, United States of America (USA) 0.84 0.69 4 -24.3%
8 Intel Corporation, United States of America (USA) 0.17 0.60 1 235.5%
9 Novome Biotechnologies, Inc., United States of America (USA) 0.50 1 N/A
10 Illumina, Inc., United States of America (USA) 0.10 0.35 4 210.9%
11 Agios Pharmaceuticals, Inc., United States of America (USA) 0.29 0.34 2 7.5%
12 BioNano Genomics, United States of America (USA) 0.13 0.33 3 128.4%
13 D. E. Shaw Research, United States of America (USA) 0.31 1 N/A
14 Leidos Holdings, Inc., United States of America (USA) 0.32 0.31 4 -10.0%
15 Gilead Sciences, Inc., United States of America (USA) 0.30 2 N/A
16 New England Biolabs, Inc. (NEB), United States of America (USA) 1.00 0.29 1 -72.6%
17 Atmospheric and Environmental Research, Inc. (AER), United States of America (USA) 0.25 1 N/A
18 Integral Molecular, Inc., United States of America (USA) 0.21 1 N/A
19 E. I. du Pont de Nemours and Company (DuPont), United States of America (USA) 0.01 0.19 3 3,057.8%
20 Puma Biotechnology, Inc., United States of America (USA) 0.17 1 N/A
21 Remote Sensing Systems (RSS), United States of America (USA) 0.14 1 N/A
22 WuXi NextCODE, United States of America (USA) 0.18 0.14 1 -29.6%
23 Sanaria Inc., United States of America (USA) 0.41 0.13 1 -71.3%
23 ICF International, Inc., United States of America (USA) 0.13 1 N/A
24 AECOM, United States of America (USA) 0.11 1 N/A
25 Bruker Corporation, United States of America (USA) 0.10 2 N/A
26 Northrop Grumman Corporation, United States of America (USA) 0.10 1 N/A
27 Pacific Biosciences of California, Inc., United States of America (USA) 0.11 0.09 2 -17.6%
28 Eli Lilly and Company, United States of America (USA) 1.00 0.09 1 -91.5%
28 Inman Mills, United States of America (USA) 0.09 1 N/A
28 Jacobs, United States of America (USA) 0.09 2 N/A
28 SomaLogic, Inc., United States of America (USA) 0.09 1 N/A
28 SPM Labs LLC, United States of America (USA) 0.09 1 N/A
29 Human Longevity, Inc., United States of America (USA) 0.09 1 N/A
30 Denali Scientific LLC, United States of America (USA) 0.08 2 N/A
31 Space Research Corporation, United States of America (USA) 0.03 0.08 3 126.1%
31 Global Science and Technology, Inc. (GST), United States of America (USA) 0.03 0.08 1 168.0%
31 CoorsTek Inc., United States of America (USA) 0.08 1 N/A
32 Quentis Therapeutics, Inc., United States of America (USA) 0.08 1 N/A
33 LabCorp, United States of America (USA) 0.08 1 N/A
33 QuSpin Inc., United States of America (USA) 0.08 1 N/A
34 AbbVie Inc., United States of America (USA) 0.65 0.07 1 -89.8%
34 Codex BioSolutions, Inc., United States of America (USA) 0.07 1 N/A
35 NVIDIA Corporation, United States of America (USA) 0.07 1 N/A
36 Geoscience Consultants LLC, United States of America (USA) 0.06 1 N/A
37 Biogen Inc., United States of America (USA) 0.18 0.06 2 -68.4%
38 RQx Pharmaceuticals, Inc., United States of America (USA) 0.06 1 N/A
39 Aerodyne Research, Inc. (ARI), United States of America (USA) 0.06 2 N/A
40 Tempus Labs, Inc., United States of America (USA) 0.05 3 N/A
41 Arbor Biosciences, LLC, United States of America (USA) 0.05 1 N/A
42 Bioqual, Inc., United States of America (USA) 0.16 0.05 1 -72.6%
43 Microsoft Corporation, United States of America (USA) 0.28 0.05 2 -84.5%
44 Immune-Onc Therapeutics, Inc., United States of America (USA) 0.04 1 N/A
45 South Texas Accelerated Research Therapeutics, LLC (START), United States of America (USA) 0.04 1 N/A
46 Focused Analysis and Research, United States of America (USA) 0.04 1 N/A
46 Theiss Research Inc., United States of America (USA) 0.04 1 N/A
47 Thermo Fisher Scientific Inc., United States of America (USA) 0.06 0.04 2 -39.2%
48 Vitrisa Therapeutics, Inc., United States of America (USA) 0.04 1 N/A
49 Aurrion, Inc., United States of America (USA) 0.04 1 N/A
50 Eureka Scientific, Inc., United States of America (USA) 0.03 0.04 1 6.5%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.